We interrogated tumours of differing grade and observed a higher expression of CD133 and CD44 in glioblastoma compared to lower grade gliomas (Figure 1A,B, right panel) in TCGA-LGG-GBM dataset. This evidence concerns the gene CD44 and glioma.